These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 34490046)

  • 21. A novel prognostic model based on telomere-related lncRNAs in gastric cancer.
    Ding X; Zhang Y; You S
    Transl Cancer Res; 2024 Sep; 13(9):4608-4624. PubMed ID: 39430825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
    Li X; Chen J; Yu Q; Huang H; Liu Z; Wang C; He Y; Zhang X; Li W; Li C; Zhao J; Long W
    Front Genet; 2021; 12():569318. PubMed ID: 33796128
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.
    Ma W; Zhong M; Liu X
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.
    Hu J; Lai C; Shen Z; Yu H; Lin J; Xie W; Su H; Kong J; Han J
    Front Oncol; 2022; 12():833763. PubMed ID: 35280814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer.
    Lu Z; Tang F; Li Z; Lai Y; Lu Z; Zhang J; Tang Z; Cai W; He Z
    Dis Markers; 2022; 2022():7931393. PubMed ID: 35154513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of a Long Non-coding RNA associated Signature to Predict Survival in Patients with Bladder Cancer.
    Zhong W; Qu H; Yao B; Wang D; Qiu J
    Cureus; 2022 May; 14(5):e24818. PubMed ID: 35693359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and validation of a five-necroptosis-related lncRNAs signature for prognostic prediction in hepatocellular carcinoma.
    Chen H; Hou G; Lan T; Xue S; Xu L; Feng Q; Zeng Y; Wang H
    Heliyon; 2024 Sep; 10(18):e37403. PubMed ID: 39309864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
    BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer.
    Zhang C; Gou X; He W; Yang H; Yin H
    Cancer Cell Int; 2020; 20():177. PubMed ID: 32467671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics.
    Pan J; Zhang X; Fang X; Xin Z
    Front Genet; 2021; 12():739470. PubMed ID: 34497636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
    Zhang R; Zhu Q; Yin D; Yang Z; Guo J; Zhang J; Zhou Y; Yu JJ
    Front Oncol; 2020; 10():597569. PubMed ID: 33614483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma.
    Xia X; Zhang H; Xia P; Zhu Y; Liu J; Xu K; Yuan Y
    Front Oncol; 2021; 11():733595. PubMed ID: 34527595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
    Huang S; Li D; Zhuang L; Zhang J; Wu J
    Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer.
    Cui Y; Zhou Z; Chai Y; Che X; Zhang Y
    J Oncol; 2021; 2021():8533464. PubMed ID: 34484338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
    Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
    J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer.
    Yu Z; Lu B; Gao H; Liang R
    J Oncol; 2022; 2022():5643496. PubMed ID: 36425941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of Glycolysis-Related LINC01070 Inhibits the Progression of Breast Cancer.
    Hu Q; Wang Y; Mao W
    Cureus; 2024 May; 16(5):e60093. PubMed ID: 38860098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A four-lncRNA risk signature for prognostic prediction of osteosarcoma.
    Liu H; Chen C; Liu L; Wang Z
    Front Genet; 2022; 13():1081478. PubMed ID: 36685868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.